Good Clinical Practice Regulations, 2009. Nigeria National Agency for Food and Drug Administration and Control (NAFDAC) Act 1993 (as amended)
(2009; 20 pages)


These regulations prescribe good clinical practice requirements for the conduct of clinical trials, including multi-centre trials, on participants involving medicinal products to ensure that the rights, safety and well-being of trial participants are protected and that the results of the clinical trials are credible.

These regulations shall also apply to clinical trials involving medicinal products for gene therapy and somatic cell therapy, including xenogenic cell therapy or medicinal products containing genetically modified organisms.

All clinical trials, including bioavailability and bioequivalence studies, shall be designed, conducted and reported in accordance with these regulations...

The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017